Petros Pharmaceuticals, Inc.

Petros Pharmaceuticals, Inc. is a U.S.-based pharmaceutical company organized around prescription erectile dysfunction products and related men’s health devices. The company has operated through subsidiaries including Metuchen Pharmaceuticals, Timm Medical Technologies, and Pos-T-Vac, with activities historically centered on Stendra® and vacuum erection devices.

2.25

2.25

— Petros Pharmaceuticals, Inc.
%
Prescription ED Pharmaceuticals60% Prescription erectile dysfunction therapy historically commercialized under the Stendra® brand.
Vacuum Erection Devices35% Mechanical erectile dysfunction devices sold through Timm Medical and Pos-T-Vac.
Self-Care OTC / ACNU Development5% Development efforts aimed at nonprescription pharmaceutical products and ACNU treatments.

The company’s historical customers include adult men seeking treatment for erectile dysfunction through prescription or...

  • ED patientsprimary

    Men seeking prescription or device-based erectile dysfunction treatment.

  • Wholesalers and distributorsprimary

    Buy and distribute Stendra® and related pharmaceutical products through commercial channels.

  • Retail/device channelssecondary

    Purchase VED products for resale to men’s health consumers.

  • OTC/self-care consumersemerging

    Future target users for nonprescription pharmaceutical products and ACNU offerings.

Petros is a U.S.-based company with operations and commercial activity historically centered in the United States...

  • •Headquartered in the United States
  • •Commercial activity historically centered in U.S. markets
  • •Subsidiaries support pharmaceutical and device operations
  • •Distribution has relied on U.S. wholesale and retail channels

Petros is repositioning its business toward nonprescription pharmaceuticals and ACNU products while evaluating internal...

01
Build a nonprescription product platformmedium-term

The company is trying to replace legacy ED revenue with self-care products that can be commercialized through broader consumer channels.

02
Pursue collaborations and acquisitionsmedium-term

External deals can add products, rights, or capabilities faster than internal development alone.

03
Secure financingshort-term

Development and commercialization require capital before new products can generate meaningful revenue.

Petros faces substantial going-concern and financing risk because it has limited operating resources and depends on...

critical

Going concern uncertainty

The company has reported negative operating cash flow and limited cash resources, creating doubt about its ability to fund operations.

Scope
Corporate liquidity and continuity of operations
Materiality
high
high

Need for additional capital

Development and commercialization require funding before new products can generate cash flow.

Scope
Equity dilution, debt burden, or reduced activity
Materiality
high
high

Transition away from legacy revenue streams

Historical ED and device businesses were discontinued or assigned, removing established revenue sources.

Scope
Revenue base and operating scale
Materiality
high
high

Regulatory and commercialization risk

OTC/nonprescription pharmaceutical products require regulatory clearance and market acceptance.

Scope
Product launch timing and adoption
Materiality
high
medium

OTC market liquidity and delisting risk

Trading on OTC markets can reduce liquidity and investor access compared with a national exchange.

Scope
Capital raising and share price volatility
Materiality
medium
Discontinued operations
Affects comparability of current-period results
Going concern assessment
Influences disclosure and asset/liability presentation
Contingencies and litigation estimates
May affect reserves and expense recognition
Settlement accounting
Can create one-time gains or balance-sheet reclassifications

Pelthos Therapeutics Inc.

PTHS · Biological Products, (No Diagnostic Substances)

MANGOCEUTICALS, INC.

MGRX · Services-Misc Health & Allied Services, NEC

Vivos Therapeutics, Inc.

VVOS · Surgical & Medical Instruments & Apparatus

Vanda Pharmaceuticals Inc.

VNDA · Pharmaceutical Preparations

Semnur Pharmaceuticals, Inc.

SMNR · Pharmaceutical Preparations

electroCore, Inc.

ECOR · Electromedical & Electrotherapeutic Apparatus

: 29/04/2026